SEC Form 4 · accession 0001572426-15-000129
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Heffernan
Officer — Chief Executive Officer
Period of report
Nov 20, 2015
Accepted (ET)
Nov 20, 2015 · 1:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Nov 20, 2015 | M | 9,204 | $0.125 | A | 243,587 | I | By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C> |
| Ordinary Shares | holding | — | — | — | 12,084 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase SharesF1,F2 | $0.125 | Nov 20, 2015 | M | 9,204 | D | — | Nov 5, 2020 | Ordinary Shares | 9,204 | 9,203 | I |
Explanation of responses
- F1The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
- F2Options to purchase 9,204 shares vested and became exercisable on 11/5/15, and the remaining 9,203 options to purchase shares will vest and become exercisable on 11/5/16.